Citigroup Maintains Buy on Biomea Fusion, Lowers Price Target to $6
Benzinga Newsdesk 11 months ago
NewsPrice TargetAnalyst Ratings
Citigroup analyst Yigal Nochomovitz maintains Biomea Fusion (NASDAQ:BMEA) with a Buy and lowers the price target from $7 to $6.
Citigroup analyst Yigal Nochomovitz maintains Biomea Fusion (NASDAQ:BMEA) with a Buy and lowers the price target from $7 to $6.